FTC commissioners dig into Impax settlement
The Federal Trade Commission’s members have questioned both sides about the balance of costs and benefits in Impax Laboratories’ reverse-payment settlement with Endo Pharmaceuticals – in the first oral arguments hearing since the agency added five new members.
To read more
Subscribe to Global Competition Review
Subscribe and start reading now
Global Competition Review (GCR) is a leading global provider of competition law, regulation and enforcement information, combining data, deep market insight and a user-centric platform to provide our clients with powerful legal solutions.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10